CG Oncology (CGON) Competitors

CG Oncology (NASDAQ:CGON) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Does the media favor CGON or ELAN?

In the previous week, Elanco Animal Health had 5 more articles in the media than CG Oncology. MarketBeat recorded 12 mentions for Elanco Animal Health and 7 mentions for CG Oncology. CG Oncology's average media sentiment score of 1.57 beat Elanco Animal Health's score of 0.54 indicating that CG Oncology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CG Oncology	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Elanco Animal Health	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, CGON or ELAN?

Elanco Animal Health has higher revenue and earnings than CG Oncology. CG Oncology is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CG Oncology	$1.14M	1,743.70	-$88.04M	-$1.51	-17.27
Elanco Animal Health	$4.43B	1.63	$338M	$0.74	19.61

Do analysts prefer CGON or ELAN?

CG Oncology currently has a consensus target price of $55.30, suggesting a potential upside of 112.04%. Elanco Animal Health has a consensus target price of $15.33, suggesting a potential upside of 5.68%. Given CG Oncology's stronger consensus rating and higher probable upside, analysts plainly believe CG Oncology is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CG Oncology	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	3.08
Elanco Animal Health	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Is CGON or ELAN more profitable?

Elanco Animal Health has a net margin of 8.43% compared to CG Oncology's net margin of -15,945.17%. Elanco Animal Health's return on equity of 7.54% beat CG Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CG Oncology	-15,945.17%	-16.71%	-16.24%
Elanco Animal Health	8.43%	7.54%	3.57%

Do insiders & institutionals have more ownership in CGON or ELAN?

26.6% of CG Oncology shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, CGON or ELAN?

CG Oncology has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500.

Summary

Elanco Animal Health beats CG Oncology on 11 of the 17 factors compared between the two stocks.